Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Ampio, Appili, Astrazeneca, Beigene, Daiichi Sankyo, Dimerix, Dr. Reddy’s, Dynavax, Eli Lilly, Eucure Beijing, Glaxosmithkline, Humanigen, I-Mab, Immutep, Innovation, Johnson & Johnson, Lead Discovery Center, Morphosys, Novavax, Oncosec Medical, Qurient, Redhill, Regeneron, Sichuan Clover, Sorrento, Takeda, Valneva, VBL, Vicore, Vir.